Search   Advanced Search
LATEST NEWS
 
 
News
 Latest Headlines
 Quick Facts
 Breaking News
 Top Stories
 Feature Articles
 Politics
 US Policy
 General
 Commodities
 Canadian
 UK
 Indian
 Wallstreet Events
 US Economic News
 European Economic News
 Asian Economic News
 All Economic News
 FX Top Stories
 Currency Alerts
 Mkt Sensitive News
 Politics
 European Mkt Updates
 Asian Mkt Updates
 Treasury Mkt Updates
 Pop
 Rock
 Classic Rock
 Rap/Hip-Hop
 Country
 Alternative
 Oldies
 Movie Reviews
 DVD Releases
 Box Office
 Slide Shows
 Business News
Commentary/Analysis
 Daily Market Analysis
 US Market Updates
 US Commentary
 Asian Commentary
 European Commentary
 Canadian Commentary
 Indian Commentary
 Sector/Market Trends
Stock Alerts
 Stocks To Watch
 Long Term Stocks
 Before the Bell
 $5 and Under
 After the Bell
 Intraday Updates
 IPOs
 Hot Stocks
Earnings Calendars
 Upcoming Earnings
 Latest Earnings
 Pos Pre Announcements
 Neg Pre Announcements
Corporate Calendars
 Stock Splits
 Stock Buybacks
 Dividends
 Conference Calls
 FDA Calendar
 Board Meetings
 Mergers & Acquisitions
Ratings Changes
 Upgrades
 Downgrades
 Coverage Initiations
 Coverage Reiterated
 All Videos
 Market Commentary
 Top Stories
 Economic News
 Political News
 Foreign Markets
 Corporate News
 Entertainment News
 Top Stories
 Earnings
 Mergers & Acquisitions
 Market Commentary
 Economic News
 IPOs and New Issues
 Corporate News
 Forex News
 Interviews
 Private Equity
Economic Calendar
RTT DeskAlert
Font Down Font Up

 
Huntsman Q3 Loss Widens - Update
11/4/2009 8:36 AM  ET

RELATED NEWS
Huntsman Q3 09 Earnings Conference Call At 8:00 AM
Huntsman Q3 Loss Widens - Quick Facts
Huntsman Announces Expiry Of U.S. Antitrust Waiting Period For Tronox Transaction - Quick Facts
Huntsman Seeks U.S. Antitrust Clearance For Tronox Asset Purchase - Quick Facts
Huntsman To Close Australian Styrenics Operations - Quick Facts
TOP MARKET NEWS
Stocks Close Mostly Lower Amid Disappointing Quarterly Results - U.S. Commentary
Stocks Remain Stuck In The Red In Mid-Afternoon Trading - U.S Commentary
Stocks Posting Moderate Losses In Early Afternoon Trading - U.S. Commentary
New Guidelines Recommend Women Wait Until 21 For Cervical Cancer Screening
Stocks Seeing Further Downside In Late Morning Trading - U.S. Commentary
(RTTNews) -  Organic and inorganic chemical products manufacturer Huntsman Corp. (HUN: News ) reported Wednesday a wider adjusted net loss for the third quarter, reflecting principally lower average selling prices, volumes and high adjusted effective tax rate. The company also said that it currently foresees the fourth quarter earnings to improve over the past year.

For the third quarter, net loss attributable to Huntsman widened to $68 million or $0.29 per share from $20 million or $0.09 per share in the previous year. The company noted that pre-tax restructuring, impairment and plant closing costs surged to $62 million from $3 million, while terminated merger and related litigation declined sharply to $2 million from $26 million in the year-ago period. The results of the latest quarter also included loss on early extinguishment of debt of $21 million and acquisition related expenses $8 million.

Excluding items, net loss widened to $55 million or $0.24 per share from $2 million or $0.01 per share, hurt by an unusually high adjusted effective tax rate, due to tax valuation allowances. On average, five analysts polled by Thomson Reuters expected the company to report loss of $0.08 per share in the third quarter. Analysts' estimates typically exclude special items.

Operating income for the three-month period plunged to $25 million from $93 million in fiscal 2008.

Revenues for the period declined 23% to $2.11 billion from $2.73 billion, mainly because of lower average selling prices across all segments and decline in sales volumes in Advanced Materials, Textile Effects and Performance Products segments. Analysts were looking for revenue of $1.95 billion for the third quarter.
Segment-wise, Polyurethanes generated revenues of $869 million, down from $1.09 billion in the past year, revenues from Advanced Materials dipped to $273 million from $385 million, and from Textile Effects decreased to $173 million from $229 million. Revenues from Performance Products slid to $540 million from $741 million, and from Pigments segment declined to $262 million from $280 million.

Peter Huntsman, Huntsman's chief executive, said, "We continue to see the positive results of our decisions during the past three years to expand our Asian operations and to focus on more differentiated chemistry while divesting of our commodity chemicals and plastics businesses. This geographic expansion and optimized product portfolio has allowed us to take advantage of markets less affected by the ongoing global recession."

To receive FREE breaking news email alerts for Huntsman Corp. and others in your portfolio


 1   2   Next Page 


Share Article:   Del.icio.us    Digg    Y! My Web    Facebook    My Space

Email        Print        

     
  Trading Center
 

More Breaking News-US

127  Indian Appointed To Key IMF Post
126  FDA Approves Bristol-Myers' Abilify To Treat Irritabilty In Pediatric Patients With Autistic Disorder - Update
125  EU Extends Review Deadline For Oracle's Proposed Takeover Of Sun Micro - Update
124  Pfizer's Geodon Approved As Adjunctive For Bipolar Disorder - Update
123  CF Nominees Enter Terra's Board - Update
122  Archipelago Learning Prices IPO Within Expected Range; Stock Soars - Update
121  Brown University And IBM Launch Multimillion-Dollar Supercomputer - Update
120  GLG Life Tech Starts Trading On Nasdaq; Shares Down 13.7% - Update
119  Global Defense Technology Prices IPO At $13/Share, Below Prior Estimate - Update
118  Dendreon Gets FDA Acceptance For Prostrate Cancer Drug Application - Update
117  Covidien's Pain Drug NDA Review Extended By FDA - Update
116  Inovio's Pre-clinincal Study Of Universal Flu Vaccines Reports Protective Response Against Multiple Influenza Strains; Stock Up - Update
115  Cloud Peak Energy Prices IPO At $15/shr - Update
114  Met-Pro Q3 Profit Plunges - Update
113  Boston Scientific Receives FDA's 510 (k)Clearance For WallFlex Fully Covered Esophageal Stent - Update
  

 

Copyright © 2009 RTTNews. All rights reserved. By using this site, you agree to the Terms of Service.

Feedback| Terms of Service | How To Use RTTNews.com| Advertise| Buy Content | RSS